| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 36,716 | 31,463 | 30,495 | 45,243 | | Cost of Revenue | 32,246 | 28,703 | 29,245 | 36,456 | | | Gross Profit | 4,470 | 2,760 | 1,250 | 8,787 | | | Operating Expenses | | Research Development | 11,025 | 10,376 | 11,625 | 12,393 | | Selling General and Administrative | 6,315 | 6,338 | 7,432 | 8,201 | | Non Recurring |
-
|
-
| 2,598 | 21,304 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (12,870) | (13,954) | (20,405) | (33,111) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 273 | 287 | (986) | (2,679) | | Earnings Before Interest And Taxes | (12,597) | (13,667) | (21,391) | (35,790) | | Interest Expense | 584 | 591 | 591 | 591 | | Income Before Tax | (13,181) | (14,258) | (21,982) | (36,381) | | Income Tax Expense | (321) |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,860) | (14,258) | (21,982) | (36,381) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,860) | (14,258) | (21,982) | (36,381) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,860) | ($14,258) | ($21,982) | ($36,381) |
|
0.10% Nasdaq 
0.28%
Income Statement
